Rhabdomyosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma
Conditions:   Soft Tissue Sarcoma;   Undifferentiated Pleomorphic Sarcoma;   Myxofibrosarcoma;   Leiomyosarcoma;   Liposarcoma;   Angiosarcoma;   Synovial Sarcoma;   Rhabdomyosarcoma;   Spindle Cell Sarcoma;   High Grade Sarcoma;   Bone Sarcoma;   Osteosarcoma;   Ewing Sarcoma of Bone Interventions:   Drug: Gemcitabine;   Drug: 9-ING-41;   Drug: Docetaxel Sponsors:   Brown University;   Actuate Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2021 Category: Research Source Type: clinical trials

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Hepatocellular Carcinoma
Conditions:   Liver Cancer;   Rhabdomyosarcoma;   Malignant Rhabdoid Tumor, Somatic;   Liposarcoma;   Wilms Tumor;   Yolk Sac Tumor Interventions:   Genetic: CATCH T cells;   Drug: Cytoxan;   Drug: Fludara Sponsors:   Baylor College of Medicine;   Center for Cell and Gene Therapy, Baylor College of Medicine;   Houston Methodist Hospital, TX Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2021 Category: Research Source Type: clinical trials